[1]Nanomedicine for urologic cancers: diagnosis and management. [2]泌尿男生殖系统同时性三重癌1例报告 [3]Case report: Synchronous prostate cancer and renal cell carcinoma with prostate cancer-origin metastases to adrenal and renal hilar lymph nodes [4]Our Current Understanding of the Heterogeneity in Prostate Cancer and Renal Cell Carcinoma [5]Insights into the impact of sodium-glucose cotransporter 2 inhibition on urinary tract malignancy: A two-sample Mendelian randomization [6]Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma [7]Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors [8]PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancer [9]Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer [10]Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8+ T-cells highly infiltrated in males